In the GLP-treated acute colitis group, the percentage of B220+CD3− cells in LPL significantly increased in GLP-treated mice, while CD3+ B220− cells in LPL significantly decreased compared with control mice, but the absolute number of B220+CD3− cells and CD3+ B220− cells showed no differences in the two groups. This evidence concerns the gene LPL and colitis.